clostridium difficile infection (cdi)
DESCRIPTION
TRANSCRIPT
WHEN ANTIBIOTICS DO MORE HARM THAN GOOD
ID ConferenceReinalyn Cartago MD
Jerome Ramos MDApril 29, 2010
To identify risk factors for acquiring Clostridium difficile infection (CDI)
To explain diagnosis and management of CDI in adult patients
To compare diagnosis and management of CDI in our institution with that of the current guidelines
To identify methods of infection prevention and control as well as environmental management of the pathogen
OBJECTIVES
I. E.
71/M
Misamis Occidental
presently residing in Marikina City
GENERAL DATA
DIARRHEA
CHIEF COMPLAINT
No known co-morbids
Alcoholic beverage drinker
40 pack yr smoker
Good Functional Capacity
PROFILE
HISTORY OF PRESENT ILLNESS
3 months PTA- (+) odynophagia/
dysphagia- Self-medicated with:
- Clarithromycin (5 doses)
- Clindamycin (5 doses)
- Co-trimoxazole unrecalled dose and duration
-Noted resolution of odynophagia
- asymptomatic and well
2 weeks PTA
- consult and subsequent admission at a local hospital - management unrecalled - Holoabdominal Ultrasound and Abdominal CT - transferred to PGH
3 weeks PTA- LBM – 10x/day- undocumented fever
- diffuse abdominal pain relieved by bowel movement- increasing abdominal girth- occl vomiting
- NO hematochezia/ melena; nor decrease in caliber of stool
HISTORY OF PRESENT ILLNESS
◦Holoabdominal UTZ liver parenchymal disease; moderate
ascites; UR GB, Pancreas, spleen, kindneys and urinary bladder
◦Abdominal CT Scan minimal ascites; fecal stasis; adynamic
ileus; mild to mod bilateral pleural effusion; non-focal thickening on antero-lateral abd wall
(+) Generalized body malaise, anorexia, undocumented weight loss
(+) dysphagia/ odynophagia (-) cough/ colds; no DOB (-) angina chest pain; no orthopnea; no
PND; no easy fatigability (-) no urinary changes (-) edema
REVIEW OF SYSTEMS
Not a known hypertensive, diabetic and asthmatic
No known allergies
1970’s – admitted for typhoid fever
PAST MEDICAL HISTORY
No known heredo-familial diseases
No history of Cancer
No similar illness in the family
FAMILY HISTORY
Alcoholic beverage drinker
40 pack yr smoker
Denies illicit drug use
PERSONAL/SOCIAL HISTORY
COURSE IN THE WARDS
◦ Awake, weak looking, not in distress
◦ 110/70 79 18 afebrile
◦ AS, PC, (-) CLAD◦ ECE, CBS◦ AP, DHS, normal rate,
irregular rhythm, no murmurs/thrills
◦ Globular, soft, nontender abdomen
◦ DRE: (+) redundant mucosa vs mass
◦ FEP, PNB, (+) grade 2 bipedal edema
ASSESSMENT:
Diarrhea probably secondary to ◦ overflow secondary to
PGO◦ r/o Colonic New Growth◦ Amoebic Colitis
T/C PGOT/C CLDR/O Typhoid Fever
ADMISSION
NPO
Metronidazole 500mg IV q6
Lansoprazole 30mg/tab, 1 tab SL
(07/23/08)
◦ WBC 21.10/ RBC 4.69/ HGb 143/ HCT 0.423/ Platelets 355/ neut 0.887/ lymph 0.043/ mono 0.064/ eos 0/ baso 0.006
◦ BUN 6.34 crea 123 alk phos 109 ast 60 alt 53 Na 133 K 4.9 Cl 101
◦ PT 12.1/ 17.6/ 0.48/ 1.70
◦ Fecalysis : Brown/ watery/mucoid/ 0-2 RBC/ 38-40 WBC; no ova or parasites; (+) occult blood
LABS
D1 D2 D3 D4 D5 D6 D7 D8 D9
(+) Loose watery stools – 4 episodes per day; Non-bloody
Afebrile
Started OF feeding
Ciprofloxacin 200mg IV q12h
Cleared for Colonoscopy
(07/24/08) DAY 1◦ BUN 6.38 crea 101 Ca 1.79 Mg 0.83 K 4.7◦ Anti HBc total – NR; Anti HCV – NR◦ Salmonella IgG – R; IgM – NR◦ Stool CS - No enteric pathogen isolated◦ Holoab UTZ - N
(07/25/08) DAY 2◦ HgbA1c 6.5 Alb 18◦ Urinalysis - Y/ Clear/ 1.020/ 6.0/ (-) sugar and
protein/ (-) RBC and WBC/ (-) cast and crystals/ (-) EC
LABS
D1 D2 D3 D4 D5 D6 D7 D8 D9
DAY 4
- Severe abdominal pain- NGT opened to drain
- with relief of abdominal pain- 200cc residuals; minimal coffee ground
- Omeprazole 40 mg IV q12 - Rebamipide 100mg/tab, 1 tab TID
DAY 5- 9 episodes of loose watery stools- EGD, Colonoscopy - Blood CS
Blood CS x 1 (07/27/08) DAY 4◦ Staphylococcus haemolyticus after 18.9 h of incubation
S: Vancomycin
Biopsy (07/28/10) DAY 5◦ Duodenum – tubulovillous adenoma◦ Acute on chronic colitis
(07/28/08) ◦ WBC 7.57/ RBC 4.67/ HGb 138/ HCT 0.42/neut 0.760/
lymph 0.120/ mono 0.100/ eos 0.010/ baso 0.010◦ Alb 17 Ca 1.76 Mg 0.90 Na 132 K 3.6
LABS
D1 D2 D3 D4 D5 D6 D7 D8 D9
COLONOSCOPY
Nodular mucosa with yellowish exudates from rectum to cecum, more severe on the left side
CLINICAL IMPRESSION: Pseudomembranous Colitis; Internal Hemorrhoids
EGD
hiatal hernia; reflux esophagitis; gastroduodenitis; duodenal polyps
DAY 5- Meds revised:oStart Vancomycin 500 mg IV q12h as continuous IV Infusion to run for 1 hoMetronidazole IV continuedoDiscontinued CiprofloxacinoEsomeprazole 40mg/tab q12h
D1 D2 D3 D4 D5 D6 D7 D8….D17
DAY 10- Metronidazole IV shifted to 500mg/tab, 1 tab q6
-Noted improvement on bowel movement- stools occurring once a day, formed
- abdominal pain completely resolved- DAT well-tolerated
-Completed 10 days of Vancomycin IV - eventually discharged improved and well
-07/30/08 crea 101 BUN 3.49 Na 143 K 3.0
- 08/02/08 crea 90 Mg 0.77 K 3.6
- 08/03/08Alb 18 Ca 1.79 Na 139
WBC 6.77/ HGb 117/ HCT 0.36/ neut 0.630/ lymph 0.230/ mono 0.100/ eos 0.030/ baso 0.010
-08/04/08 Phos 0.81
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17
SUMMARY OF COURSEHOSPITAL DAY
Metronidazole 500mg IV q6h
Metronidazole 500mg /tab , 1 tab q6h
Ciprofloxacin200 mg IV
q12h
Vancomycin 500mg IV q12h
LBM x 4BM x 9
BM x 1
Resolution of LBM
WBC21.1
WBC7.57
WBC6.77
TAKE HOME MEDS:
Esomeprazole 40 mg/tab, BIDRebamipide 100 mg/tab, TID x 2 wksMetronidazole 500 mg/tab, TID x 2 more daysMebeverine tab, TID x 1 week
FINAL DIAGNOSIS
PSEUDOMEMBRANOUS COLITIS
What are possible causes of chronic diarrhea in an elderly patient with questionable history of prolonged antibiotic use?
ISSUES
For patients with CDI, is there a need to do toxin assay if colonoscopy already reveals pseudomembranes?
Is it prudent to treat patients as CDI based on clinical grounds only?
ISSUES
Is there a need to give both Metronidazole and Vancomycin in our patient?
What is the appropriate route and duration of treatment of CDI
ISSUES
DISCUSSION
20% - 30% of antibiotic associated diarrhea Few surveillance data in US
3.4 – 8.4 per 1,000 admissions in CanadaClinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare
Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
EPIDEMIOLOGY
Atlanta GA--rates of Clostridium difficile infections (CDI) surpassed infection rates for methicillin-resistant Staphylococcus aureus (MRSA) in South East US Hospitals
Becky Miller, MD, Duke Infection Control Outreach Network, Duke University, 2009.
EPIDEMIOLOGY
“CDAD should probably not be the first consideration when a patient in the ICUs of UP-PGH (2004) develops Nosocomial Diarrhea”
“…at least 2 specimens should be sent for C. difficile testing if the suspicion for CDAD is strong”
Gutierrez MD., UP-PGH, 2004
EPIDEMIOLOGY
Exposure to antimicrobial agents◦ Clindamycin, Ampicillin, Cephalosporins, Fluoroquinolones
Advanced Age Greater severity of underlying illness Duration of Hospitalization Gastric Surgery Use of rectal thermometers Enteral tube feeding Antacids, PPI
RISK FACTORS
PATHOGENESIS
What are possible causes of chronic diarrhea in an elderly patient with questionable history of prolonged antibiotic use?
ANSWERS TO ISSUES
For patients with CDI, is there a need to do toxin assay if colonoscopy already reveals pseudomembranes?
Is it prudent to treat patients as CDI based on clinical grounds only?
ANSWERS TO ISSUES
Is there a need to give both Metronidazole and Vancomycin in our patient?
What is the appropriate route and duration of treatment of CDI
ANSWERS TO ISSUES
THANK YOU!!!
6% rate of resistance to metronidazole among 78 isolates of C. difficile
◦ Peláez et al.,38th ICAAC
In 1997, high-level metronidazole resistance demonstrated in C. difficile isolates obtained from horses S. S. Jang, et al. 35th Annual Meeting of Infectious Diseases Society of America 1997, Clin. Infect. Dis. 25(Suppl. 2):S266–S267,
1997]
Highest rate of metronidazole resistance was observed in HIV-infected patients
T. Peláez, L. Alcalá, R. Alonso,* M. Rodríguez-Créixems, J. M. García-Lechuz, and E. Bouza, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2002, p. 1647–1650
METRONIDAZOLE RESISTANCE
“…clinical isolates of Clostridium difficile with resistance to metronidazole is 6.3%.”◦ not due to the presence of nim genes◦ resistance to metronidazole in toxigenic C. difficile
isolates is heterogeneous◦ prolonged exposure to metronidazole can select
for in vitro resistance◦ routine performance of the disk diffusion method
(5-microg metronidazole disk) J Clin Microbiol. 2008 Sep;46(9):3028-32. Epub 2008 Jul 23
METRONIDAZOLE RESISTANCE
Oral rifaximin (Xifaxan®; Salix Pharmaceuticals, Inc, Morrisville, NC) 1200 mg/d for 14 days ◦ Gut-selective, non-systemic antibiotic
METRONIDAZOLE RESISTANCE